ico

Catalonia, a hub of global biomedical research

July 25, 2014 12:32 PM | Bryony Clarke

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.

Catalan Oncology Institute will pay Roche drugs depending on clinical results

January 24, 2014 07:47 PM | ACN

The Catalan Institute of Oncology (ICO) and Roche pharmaceutical company have signed an agreement stating that the Catalan public institute will pay for treatments against cancer depending on clinical results adapted to each specific patient. For now, the agreement provides that Roche will supply two drugs against the most common cancers, mostly breast and colon. According to the agreement, the probabilities of success will be thoroughly examined and if they meet the requirements, the Catalan Government will fully pay for the treatment. If not, Roche will assume the costs progressively according to the degree of success.

The Mediterranean diet reduces by 6% the risk of developing breast cancer

February 14, 2013 03:57 PM | CNA / Elise Griset

Researchers from the Catalan Institute of Oncology have led the largest international study on breast cance4r and nutrition. The 8-year study has been based on 335,062 women between 35 and 70 years old. It has involved 23 centres in 10 European countries and it has been published in the ‘International Journal of Cancer’. The study concludes that the Mediterranean diet can reduce the risk of breast cancer by 6% among women in general and 7% in the case of post-menopausal patients.

The Catalan Oncology Institute gets maximum international distinction for its fight against tobacco

May 21, 2012 11:04 PM | CNA / Adrià Attardi

The centre received the ‘Gold Level Award’ from the Global Network for Tobacco Health Care Services, thanks to its fight against the effects of smoking. The jury emphasised the training given to both hospital workers and patients in order to give up smoking and the achievement of a strict non-smoking area in this health centre’s facilities. Only ten hospitals around the world have this distinction, among them another Catalan institution: Sant Joan de Déu Hospital in Manresa, in Central Catalonia.